NTRK3 and breast cancer: NTRK protein binding partners mainly affect tumourigenesis or survival in BC patients, particularly those with NTRK gene fusions through oncogenic mechanisms—for instance, ETV6-NTRK3, an infrequently occurring but potent oncogenic driver in secretory breast carcinoma.